Skip to content
Clinical Trials – home

Del-Pesti Centrumkorhaz Orszagos Hematologiai Es Infektologiai Intezet

Verified siteinfo

Hungary Nagyvarad Ter 1, 1097 Budapest, Hungary

  • 21 trials recruiting
  • Plasma cell myeloma · Sjogren's syndrome · Systemic lupus erythematosus
  • Adults and children

About Specializations

Del-Pesti Centrumkorhaz Orszagos Hematologiai Es Infektologiai Intezet in Budapest, Hungary specialises in clinical trials of conditions such as Plasma cell myeloma, Sjogren's syndrome, Systemic lupus erythematosus, Chronic lymphocytic leukaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

Clinical research at Del-Pesti Centrumkorhaz Orszagos Hematologiai Es Infektologiai Intezet focuses on cardiovascular diseases, especially atherosclerotic cardiovascular disease and related risk conditions. The studies are designed to test whether new treatments can better prevent serious heart and blood vessel events in people at elevated risk.

  • Prevention of major adverse cardiovascular events in high-risk patients
  • Evaluation of therapies for atherosclerotic heart and blood vessel disease
  • Research on reducing cardiovascular risk linked to lipoprotein disorders

These trials aim to improve treatment effectiveness and support earlier prevention strategies for patients with significant cardiovascular risk.

Nutritional and Metabolic Diseases

The site also conducts studies in nutritional and metabolic diseases, with a strong emphasis on obesity and overweight. This research explores whether newer therapies can help lower weight-related health risks and improve long-term outcomes for adults living with metabolic conditions.

  • Testing treatment approaches for obesity
  • Clinical research in overweight and related metabolic risk
  • Assessing therapies that may reduce morbidity and mortality in obesity

Overall, the trials are aimed at improving disease control, lowering complications, and supporting better prevention of cardiovascular and metabolic problems.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Nagyvarad Ter 11097 BudapestHungary
Recruiting now
21 trials
Conditions studied
63
Partner status
Verified site

More sites in BudapestHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

81 clinical trials

A Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

A Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BI 456906
  • Sponsor:Boehringer Ingelheim International GmbH

A study to evaluate the safety of dazodalibep in patients with Sjögren's Syndrome over a long period of time

InvestigationalNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.

Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:BIO89-100
  • Sponsor:F. Hoffmann-La Roche AG

Prophylactic Tocilizumab to Prevent Cytokine Release Syndrome in Relapsed/Refractory Multiple Myeloma Patients Receiving JNJ-79635322 and Human Normal Immunoglobulin (IV)

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Janssen Cilag International

Study of blinatumomab and a drug combination for older adults with newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Asparaginase
  • Sponsor:Amgen Inc.

Study of ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Kura Oncology Inc.

Evaluation of Long-Term Safety and Efficacy of Litifilimab in Adults with Active Systemic Lupus Erythematosus: A Phase 3 Multicenter, Randomized, Dose-Blind Study

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Litifilimab
  • Sponsor:Biogen Idec Research Limited

Testing Stem Cell Transplant Methods and Medications Including Ruxolitinib and Blinatumomab for Children and Young Adults with Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Ospedale Pediatrico Bambino Gesu

Study of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia

Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Rilzabrutinib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Study of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:Janssen Cilag International

Study Comparing BMS-986393 CAR T Cell Therapy to Standard Treatments for Adults with Relapsed or Refractory Multiple Myeloma Resistant to Lenalidomide

Registered drugNo placebo
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Celgene Corp.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.